N. Cabrera

One‐stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

Ana Rosa Cid, Mar. G. Calabuig, Vicente Cortina et al. · Haemophilia · 2008 · 61 citations

Medicine, Genetics, Molecular Genetics +17

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method

N. Cabrera, Andrés Moret, P. Caunedo et al. · Haemophilia · 2013 · 35 citations

Medicine, Hematology, Pathology +12

Severe and moderate hemophilia A: identification of 38 new genetic alterations

Pilar Casaña, N. Cabrera, Ana Rosa Cid et al. · Haematologica · 2008 · 26 citations · Full text

Medicine, Genetics, Hematology +17

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B

Toshko Lissitchkov, Michał Matysiak, K. Zavilska et al. · Haemophilia · 2011 · 21 citations

Medicine, Hematology, Pharmacokinetics +15

Pharmacokinetic study of a high‐purity factor IX concentrate (Factor IX Grifols^®) with a 6‐month follow up in previously treated patients with severe haemophilia B

José A. Aznar, N. Cabrera, Michał Matysiak et al. · Haemophilia · 2009 · 16 citations · Full text

Medicine, Hematology, Pharmacology +13